|

Bevacizumab Injection Clinical Trials

8 actively recruiting trials

Also known as: Bevacizumab, Pobevcy

Pipeline

Phase 2: 4Phase 1/2: 3Phase 2/3: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.3
  • Shanghai Hengrui Pharmaceutical Co., Ltd.2
  • Nanjing Leads Biolabs Co.,Ltd2
  • Bio-Thera Solutions1

Indications

  • Cancer8
  • Advanced Solid Tumour2
  • Advanced Solid Tumors2
  • Recurrent or Metastatic Cervical Cancer1
  • Advanced or Metastatic Non-small Cell Lung Cancer1

Other8 trials

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
Phase 2
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Phase 2
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Phase 2
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
Phase 1/2
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Phase 1/2
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
Phase 2
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
Phase 2/3
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.